Clinical Trial: A Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled Syringe

U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07890909) titled 'A Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled Syringe' on Oct. 15.

Brief Summary: The purpose of this study is to evaluate participant treatment experience with Povetacicept injection administered via autoinjector relative to Sibeprenlimab injection administered via prefilled syringe (PFS), and to assess the safety and tolerability of Povetacicept in participants with Immunoglobulin A nephropathy (IgAN).

Study Start Date: Oct. 23

Study Type: INTERVENTIONAL

Condition: Immunoglobulin A Nephropathy

Intervention: DRUG: Povetacicept ...